| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenue | 363,809 | 345,311 | 332,970 | 312,722 |
| Center costs, excluding depreciation and amortization shown separately below | 247,227 | 236,880 | 223,179 | 212,291 |
| General and administrative expenses | 95,615 | 97,375 | 94,431 | 85,269 |
| Depreciation and amortization | 13,557 | 14,006 | 13,756 | 15,115 |
| Total operating expenses | 356,399 | 348,261 | 331,366 | 312,675 |
| Income (loss) from operations | 7,410 | -2,950 | 1,604 | 47 |
| Gain on remeasurement of contingent consideration | 0 | 0 | 0 | 15 |
| Transaction costs | 0 | 0 | - | 29 |
| Interest expense, net | 2,814 | 2,900 | 3,073 | 5,413 |
| Other expense | 24 | 92 | 1 | 2 |
| Total other expense | -2,838 | -2,992 | -3,074 | -5,429 |
| Income (loss) before income taxes | 4,572 | -5,942 | -1,470 | -5,382 |
| Income tax (provision) benefit | 3,495 | -2,151 | -2,179 | 575 |
| Net income (loss) | 1,077 | -3,791 | 709 | -5,957 |
| Unrealized losses on cash flow hedge, net of tax | -345 | -267 | -317 | -1,872 |
| Comprehensive income (loss) | 732 | -4,058 | 392 | -7,829 |
| Weighted average number of shares outstanding, basic | 386,963,000 | 386,733,000 | 383,272,000 | 380,359,000 |
| Weighted average number of shares outstanding, diluted | 388,895,000 | 386,733,000 | 390,666,000 | 380,359,000 |
LifeStance Health Group, Inc. (LFST)
LifeStance Health Group, Inc. (LFST)